Preoperative Methenamine Discontinuation
Methenamine is not recommended for perioperative antimicrobial treatment of asymptomatic bacteriuria, but available perioperative studies used methenamine hippurate started shortly before or on the day of surgery rather than discontinued preoperatively for that indication. [1]
Indication-Dependent Perioperative Management
Methenamine should not be considered a substitute for antimicrobial therapy when treatment for symptomatic urinary tract infection or perioperative management of proven infection is required. [1] In trials of patients with asymptomatic bacteriuria undergoing urologic procedures, methenamine hippurate was used in a perioperative dosing strategy that began before surgery rather than being stopped immediately preoperatively. [1], [2]
Evidence Supporting Perioperative Use (Not Routine Preoperative Stop)
A randomized trial in patients with asymptomatic bacteriuria undergoing TURP compared preoperative antimicrobials with methenamine hippurate and reported substantially higher postoperative fever rates with methenamine hippurate than with cefotaxime, supporting non-use as a perioperative antimicrobial strategy rather than a recommendation to discontinue. [1] Perioperative dosing regimens in surgical prophylaxis studies included methenamine hippurate administered the night before and on the day of surgery, which supports continuation through the perioperative window when methenamine is being used for urinary antisepsis prophylaxis rather than acute infection treatment. [2]
Monotherapy vs Combination Therapy
Methenamine monotherapy should not be selected as perioperative antimicrobial coverage for asymptomatic bacteriuria. [1] If treatment for infection becomes indicated based on symptoms and diagnostic evaluation, standard antimicrobial regimens should be used rather than relying on methenamine. [1]
Initiation and Timing Principles for Surgical Patients
In perioperative UTI prophylaxis studies, methenamine hippurate administration was started within 24 hours of surgery and continued through the immediate postoperative period in some protocols. [2] Routine preoperative discontinuation is not supported by evidence when methenamine is being continued for urinary antisepsis prophylaxis rather than being used as a treatment strategy for established infection. [2]
Common Pitfalls to Avoid
Avoid interpreting perioperative methenamine use as evidence that methenamine provides adequate antimicrobial treatment of asymptomatic bacteriuria. [1] Avoid perioperative decision-making based solely on “preventing bacteriuria” goals without assessing whether symptoms or infection criteria are present. [1]
Safety and Contraindication Checks Around Surgery
Methenamine hippurate should be avoided in severe renal impairment (e.g., eGFR <10 mL/min/1.73 m²) and should be avoided in hepatic dysfunction per prescribing guidance in perioperative drug monographs. [3] Drug interaction screening should be performed to avoid concurrent alkalinizing agents and sulfonamides. [3]
Targets and Goals
The goal for perioperative urinary management should be based on whether asymptomatic bacteriuria is present and whether infection treatment is indicated, since methenamine is not recommended as perioperative antimicrobial therapy for asymptomatic bacteriuria. [1]